Skip to main content

Mintz Members Bill Whelan and Yalonda Howze to Speak at the Boston Bar Association’s 2019 Life Sciences Conference

Mintz Member and Co-chair of the firm’s Life Sciences Practice William T. Whelan and Mintz Member Yalonda T. Howze will be featured speakers at the Boston Bar Association’s 2019 Life Sciences Conference, to be held on October 23 in Boston.

The annual conference brings together Boston-area life sciences practitioners and industry experts from in-house legal departments, law firms, academia, and government to explore the interplay between the life sciences industry and the law.

Mr. Whelan will address legal considerations for life sciences clients at a critical point of the corporate life cycle during a panel discussion titled “A Fork in the Road – Go Public, Stay Private, or Sell the Company?”

In his role as Co-chair of Mintz’s Life Sciences Practice, Mr. Whelan focuses his practice on securities law, venture capital, and mergers and acquisitions. He applies his extensive mergers and acquisitions and venture capital financing experience primarily to deal work for life sciences companies, including biotechnology, medical technology and healthcare IT companies, among others. He also counsels venture capital firms on their portfolio investments.

Separately, Ms. Howze will participate in a panel discussion titled “Strategies for Managing Law Firm and In-House Legal Department Relationships and Budget Priorities.” Ms. Howze is a Mintz litigator and relationship partner with a focus on the life sciences industry. She assembles cross-functional teams that take a collaborative approach to meet clients' needs. Ms. Howze and her team also conduct comprehensive product risk and compliance assessments.

Mintz is one of the leading law firms to the life sciences industry. The firm’s attorneys advise hundreds of businesses and other organizations across the sector’s ecosystem—from start-ups and emerging growth companies to large public companies as well as venture capital firms, investment banks, and research and academic institutions—in a broad range of mission-critical transactional, intellectual property, regulatory, and litigation matters. 

For more information about Mintz, please visit